Expertise in
66
conditions

W L. Han-Wei

30 Zhongyang Road, 
Nanjing, CN 
Expertise in
66
conditions
30 Zhongyang Road, 
Nanjing, CN 

Overview

W Han-Wei practices practicing medicine in Nanjing, China.

Han-Wei is highly rated in 66 conditions, according to our data. Their clinical expertise encompasses Graft Versus Host Disease (GvHD), Gliomatosis Cerebri, Glioma, Bone Marrow Transplant, and Endoscopy.

They are actively involved in clinical research, co-authoring 2201 peer reviewed articles and participating in 2 clinical trials.

Locations

30 Zhongyang Road, Nanjing, 210008, China
Other Locations
1 Jiaozhou Road, Qingdao, China
No. 150 Ji Mo Rd, Shanghai, 200120, China
Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing, 100005, China
1163 Xinmin Street, Changchun, 130021, China
No. 88 Jiefang Road, Hangzhou, 310009, China
No. 30 Zhongyang Road, Nanjing, 210008, China
No. 1 Xinsi Road, Xi'an, China
No. 1 Xinsi Road, Xi'an, 710038, China
76 West Yanta Road, Xi'an, 710061, China
No. 71 Xinmin Street, Changchun, China
Taicheng Road NO.3, Yangling, 712100, China
No. 1, Jiaozhou Road, Qingdao, 266011, China
No.185, Juqian Street, Changzhou, 213003, China
No. 139 Renmin Road, Changsha, 410011, China
NO. 70 Qutangxia Road, Qingdao, 266002, China
56 Nanlishi Road, Beijing, 100045, China
Department Of PET CT, Harbin, 150001, China
76 Yanta West Road, Xi'an, 710061, China
High Magnetic Field Laboratory, Hefei, China
600# Yishan Road, Xuhui, 200233, China
No. 256 Youyi West Road, Xi'an, 710068, China
1 East Jianshe Rd, Zhengzhou, 450052, China
Zhongguancun Avenue 59, Haidian, China
Union Hospital, Wuhan, 430022, China
No. 1 Jian Guo Men, Wai Avenue, Beijing, China
West Beigong Road 256, Weifang, 261021, China
361 East Zhongshan Road, Shijiazhuang, 050017, China
95 Wenhua Road, Zhengzhou, 450002, China
639 Longmian Avenue, Nanjing, 211198, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
A Phase III, 12 Week, Randomized, Double-blind, 4 Arm Parallel Group Bridging Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination FF/UMEC/VI Once-daily Via a Dry Powder Inhaler With Dual Combination of FF/VI, Administered in Chinese Participants With Inadequately Controlled Asthma
Enrollment Status: Completed
Publish Date: August 11, 2025
Intervention Type: Device, Drug
Study Drugs: FF/VI, FF/UMEC/VI
Study Phase: Phase 3
A Randomized, Double Blind, Parallel Group Study of the Efficacy and Safety of Mepolizumab as Adjunctive Therapy in Patients With Severe Asthma With Eosinophilic Inflammation
A Randomized, Double Blind, Parallel Group Study of the Efficacy and Safety of Mepolizumab as Adjunctive Therapy in Patients With Severe Asthma With Eosinophilic Inflammation
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drugs: Mepolizumab, Salbutamol
Study Phase: Phase 3
View 1 Less Clinical Trial

2201 Total Publications

Outcomes of patients with hematological malignancies complicated with autoimmune diseases after allogeneic hematopoietic stem cell transplantation: A ten-year real-world study.
Outcomes of patients with hematological malignancies complicated with autoimmune diseases after allogeneic hematopoietic stem cell transplantation: A ten-year real-world study.
Journal: Journal of translational internal medicine
Published: August 27, 2026

Frequently Asked Questions about W L. Han-Wei

Is W L. Han-Wei a top-rated expert for Bone Marrow Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. W L. Han-Wei is classified as an Distinguished expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does W L. Han-Wei participate in research or clinical trials?

Yes. W L. Han-Wei has published 2201 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of W L. Han-Wei's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Han-Wei's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 59 Advanced Conditions
    View All 239 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile